Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer
Sara Bobisse(Ludwig Cancer Research), Alexandre Harari(Ludwig Cancer Research)
Cited by 166
Related Papers
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes
|Cell Systems|2023|114
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
|Nature Communications|2023|66
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
|Cell Reports Methods|2023|48